Collie White
FCI Group
Not Recognized
AKC Group
Not Recognized
TKC Group
Not Recognized
Country of Origin
US
Health Testing Requirements by Country
Test Relevances
Multidrug Resistance 1 (MDR1)
Strong Relevance
Hyperuricosuria and Hyperuricemia (HUU)
Moderate Relevance
Canine Cyclic Neutropenia (Grey Collie Syndrome)
Some Relevance
Collie Eye Anomaly (CEA/CH)
Some Relevance
Degenerative Myelopathy
Some Relevance
Dermatomyositis
Some Relevance
Progressive Retinal Atrophy rcd2 (PRA-rcd2)
Some Relevance
Pyruvate Kinase Deficiency
No Evidence
Von Willebrand Disease I
No Evidence
Von Willebrand Disease II
No Evidence
Coat Colour Dilution, dilution, MLPH-related
No Evidence
Multidrug Resistance 1 (MDR1)
Strong Relevance
Hyperuricosuria and Hyperuricemia (HUU)
Moderate Relevance
Canine Cyclic Neutropenia (Grey Collie Syndrome)
Some Relevance
Collie Eye Anomaly (CEA/CH)
Some Relevance
May be relevant across many breeds, including those not specified in the literature, but of shared origins. Several reports have been raised that in some breeds the causality of the mutation may be complex. Clinical diagnosis may be especially important to the individual dog.
Degenerative Myelopathy
Some Relevance
Both clinically rare and of complex inheritance. Test is considered poorly correlated with risk for development of DM, and recommendations are to not use the test for breed-wide breeding strategies, even where there is some evidence of the presence of DM in the breed. While the SOD 1 variant may be commonly found across many breeds, there are few clinical cases observed and confirmed, and in many cases DM has never been observed in the breeds.
Dermatomyositis
Some Relevance
Progressive Retinal Atrophy rcd2 (PRA-rcd2)
Some Relevance
Pyruvate Kinase Deficiency
No Evidence
Von Willebrand Disease I
No Evidence
Mutation is widespred, so may be relevant
Von Willebrand Disease II
No Evidence
Coat Colour Dilution, dilution, MLPH-related
No Evidence
- Updated
- Add Breed